Roles of trinucleotide-repeat RNA in neurological disease and degeneration
暂无分享,去创建一个
[1] M. Nakamori,et al. Pentamidine reverses the splicing defects associated with myotonic dystrophy , 2009, Proceedings of the National Academy of Sciences.
[2] B. Wieringa,et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy , 2009, Proceedings of the National Academy of Sciences.
[3] T. Ebner,et al. RNA Gain-of-Function in Spinocerebellar Ataxia Type 8 , 2009, PLoS genetics.
[4] Krzysztof Sobczak,et al. Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA , 2009, Science.
[5] Michael Fry,et al. The quadruplex r(CGG)n destabilizing cationic porphyrin TMPyP4 cooperates with hnRNPs to increase the translation efficiency of fragile X premutation mRNA , 2009, Nucleic acids research.
[6] Hwan‐Ching Tai,et al. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction , 2008, Nature Reviews Neuroscience.
[7] S. Warren,et al. Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function , 2008, Neuron.
[8] Christina Thaller,et al. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis , 2008, Nature Neuroscience.
[9] E. Futai,et al. MBNL1 associates with YB‐1 in cytoplasmic stress granules , 2008, Journal of neuroscience research.
[10] N. Bonini,et al. RNA toxicity is a component of ataxin-3 degeneration in Drosophila , 2008, Nature.
[11] T. Cooper,et al. Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy , 2008, Proceedings of the National Academy of Sciences.
[12] S. Tapscott,et al. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. , 2007, Human molecular genetics.
[13] Guey-Shin Wang,et al. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. , 2007, Molecular cell.
[14] Jessica Treisman,et al. The Conserved microRNA MiR-8 Tunes Atrophin Levels to Prevent Neurodegeneration in Drosophila , 2007, Cell.
[15] T. M. Wheeler,et al. Myotonic dystrophy: RNA-mediated muscle disease , 2007, Current opinion in neurology.
[16] P. Jin,et al. RNA-Binding Proteins hnRNP A2/B1 and CUGBP1 Suppress Fragile X CGG Premutation Repeat-Induced Neurodegeneration in a Drosophila Model of FXTAS , 2007, Neuron.
[17] P. Jin,et al. Pur α Binds to rCGG Repeats and Modulates Repeat-Mediated Neurodegeneration in a Drosophila Model of Fragile X Tremor/Ataxia Syndrome , 2007, Neuron.
[18] M. Swanson,et al. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs , 2007, Nucleic acids research.
[19] P. Greengard,et al. Cerebellar neurodegeneration in the absence of microRNAs , 2007, The Journal of experimental medicine.
[20] H. Zoghbi,et al. Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.
[21] J. Krol,et al. Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. , 2007, Molecular cell.
[22] N. Bonini,et al. A New Role for MicroRNA Pathways: Modulation of Degeneration Induced by Pathogenic Human Disease Proteins , 2006, Cell cycle.
[23] M. Swanson,et al. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. F. Atkins,et al. The potential role of ribosomal frameshifting in generating aberrant proteins implicated in neurodegenerative diseases. , 2006, RNA.
[25] T. Ebner,et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8 , 2006, Nature Genetics.
[26] T. Cooper,et al. RNA-mediated neuromuscular disorders. , 2006, Annual review of neuroscience.
[27] P. Hagerman,et al. Protein composition of the intranuclear inclusions of FXTAS. , 2006, Brain : a journal of neurology.
[28] S. Tapscott,et al. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. , 2005, Molecular cell.
[29] S. Batalov,et al. Antisense Transcription in the Mammalian Transcriptome , 2005, Science.
[30] T. Cooper,et al. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. , 2005, Human molecular genetics.
[31] M. Swanson,et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. , 2004, Human molecular genetics.
[32] T. Cooper,et al. Muscleblind proteins regulate alternative splicing , 2004, The EMBO journal.
[33] P. Lockhart,et al. Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2) , 2004, Movement disorders : official journal of the Movement Disorder Society.
[34] W. Hauswirth,et al. A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.
[35] K. Usdin,et al. The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. , 2003, Nucleic acids research.
[36] K. Khalili,et al. Purα Is Essential for Postnatal Brain Development and Developmentally Coupled Cellular Proliferation As Revealed by Genetic Inactivation in the Mouse , 2003, Molecular and Cellular Biology.
[37] Peng Jin,et al. RNA-Mediated Neurodegeneration Caused by the Fragile X Premutation rCGG Repeats in Drosophila , 2003, Neuron.
[38] Erez Y. Levanon,et al. Widespread occurrence of antisense transcription in the human genome , 2003, Nature Biotechnology.
[39] P. Auluck,et al. Pharmacological prevention of Parkinson disease in Drosophila , 2002, Nature Medicine.
[40] D. Munoz. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. , 2002, Neurology.
[41] T. Cooper,et al. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy , 2001, Nature Genetics.
[42] S. Naylor,et al. Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.
[43] R. Wilson,et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X , 2001, Neurology.
[44] C. Ross,et al. SCA-12: Tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion , 2001, Neurology.
[45] C. Ross,et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2 , 2001, Nature Genetics.
[46] L. Schut,et al. Spinocerebellar ataxia type 8 , 2000, Neurology.
[47] R. J. White,et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.
[48] D. Turner,et al. Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. , 2000, RNA.
[49] H. Paulson,et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 , 1999, Nature Genetics.
[50] T. Bird,et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) , 1999, Nature Genetics.
[51] M. Swanson,et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. , 1996, Nucleic acids research.
[52] R. Griggs,et al. Myotonic dystrophy with no trinucleotide repeat expansion , 1994, Annals of neurology.
[53] Shigenobu Nakamura,et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.
[54] C. Amemiya,et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.
[55] T. Ashizawa,et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.
[56] David E. Housman,et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.